About Aster Prime Hospitals
Aster Prime Hospitals is a publicly listed company based in Hyderabad (India) founded in 2006 by Devanand Kolothodi. Multi-speciality hospital providing advanced medical care and treatments in Hyderabad. It operates on a B2C and D2C model. The company has 4,431 employees. Its Indian entity Aster Dm Quality Care Limited reported revenue of ₹4,807 Cr. Aster Prime Hospitals offers products and services including Medical Consultation, Emergency Services, and Virtual Consultations. Its focus areas include Hospital Services, Multi-Speciality, Quaternary Care and Medical Specialities. Similar companies include Fortis Healthcare, Ujala Cygnus and Narayana Health; 2 of its 3 listed similar companies have raised funding.
Company details
Aster Prime Hospital is a private multi-speciality facility in Hyderabad, Telangana, offering quaternary medical care with state-of-the-art technology. It provides services in areas like cardiac sciences, neurology, and orthopaedics through skilled experts. The hospital focuses on diagnosis, treatment, and personalized care for faster patient recovery, serving local and international patients with round-the-clock support.
- Headquarters Hyderabad, India
- Employees 4,431
- Founders Devanand Kolothodi
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website asterprime.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Aster Dm Healthcare Limited
- Date of Incorporation 18 Jan, 2008
- Jurisdiction Bangalore, Karnataka, India
- Market Cap₹62,721 Cr
ASTERDM · NSE
- Share Price₹713.15
-0.89% today
- Revenue₹4,643 Cr
FY 2025-26 · +12.2% YoY
- EBITDA₹802 Cr
Margin 17.3%
- Net Profit₹411 Cr
FY 2025-26 · +176.0% YoY
- P/E (TTM)161.6x
P/B 14.9x
- ROE12.7%
ROCE 11.8%
- Debt / Equity0.58
Interest cover 24.5x
- Employee Count4,431
Associated legal entities of Aster Prime Hospitals
Aster Prime Hospitals is associated with 2 registered companies on The Company Check; the primary company is Aster Dm Quality Care Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aster Dm Quality Care Limited Listed CIN L85110TS2008PLC207383 | Active | 18 Jan 2008 | Hyderabad, Telangana | ₹4,807 Cr | 4,431 | 15 | View details |
| Aster Dm Healthcare Limited CIN L85110KA2008PLC147259 | 18 Jan 2008 | Bangalore, Karnataka, India | View details |
Products & Services of Aster Prime Hospitals
Aster Prime Hospitals offers a comprehensive portfolio of products and services, including Medical Consultation, Emergency Services, and Virtual Consultations.
Expert advice and treatment for various medical conditions
24/7 response for acute medical emergencies
Online appointments for follow-up and initial consultations
Apps and channels of Aster Prime Hospitals
its YouTube channel Aster DM Healthcare, India has 1.15K subscribers and 30 videos.
Videos from Aster Prime Hospitals
The most watched videos on Aster Prime Hospitals's YouTube channel, Aster DM Healthcare, India (1.15K subscribers). Click a video to play it here.
More on Aster DM Healthcare, India.
Board of directors of Aster Dm Quality Care Limited (Aster Prime Hospitals)
Aster Dm Quality Care Limited is the primary company behind Aster Prime Hospitals. The board of Aster Dm Quality Care Limited currently have 12 directors; the longest-serving is Mandayapurath Azad Moopen, appointed in 2008. 31 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mandayapurath Azad Moopen DIN 00159403 | Whole-time director | 18 Jan 2008 | 18 yrs 9 mo | Aster Dm Quality Care Limited |
| Thadathil Joseph Wilson DIN 02135108 | Director | 20 Apr 2009 | 17 yrs 6 mo | Aster Dm Quality Care Limited |
| Alisha Moopen DIN 02432525 | Whole-time director | 20 Sep 2013 | 13 yrs 1 mo | Aster Dm Quality Care Limited |
| James Mathew DIN 07572909 | Director | 23 Jun 2020 | 6 yrs 4 mo | Aster Dm Quality Care Limited |
| Purana Housdurgam Vijaya Deepti DIN 08125456 | Director | 27 Mar 2023 | 3 yrs 7 mo | Aster Dm Quality Care Limited |
| Sunil Theckath Vasudevan DIN 00294130 | Director | 31 Jul 2024 | 2 yrs 3 mo | Aster Dm Quality Care Limited |
| Ayshwarya Ravi Vikram DIN 08153649 | Additional Director | 01 Jul 2026 | 4 mo | Aster Dm Quality Care Limited |
| Ganesh Mani DIN 08385423 | Additional Director | 01 Jul 2026 | 4 mo | Aster Dm Quality Care Limited |
| Neeraj Jain DIN 00348591 | Additional Director | 01 Jul 2026 | 4 mo | Aster Dm Quality Care Limited |
| Varun Shadilal Khanna DIN 03584124 | Managing Director | 01 Jul 2026 | 4 mo | Aster Dm Quality Care Limited |
| Valayil Korath Mathews DIN 00049414 | Additional Director | 01 Jul 2026 | 4 mo | Aster Dm Quality Care Limited |
| Kewal Kundanlal Handa DIN 00056826 | Additional Director | 01 Jul 2026 | 4 mo | Aster Dm Quality Care Limited |
People of Aster Prime Hospitals
1 people are tracked at Aster Prime Hospitals (1 in leadership); the tracked headcount is 4,431.
| Name | Role | Group |
|---|---|---|
Devanand Kolothodi | Founder | Leadership |
Complete people profiles for Aster Prime Hospitals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Aster Prime Hospitals
Aster Prime Hospitals is a publicly listed company on the NSE with ticker symbol ASTERDM in India, operating in the Healthcare sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: ASTERDM
- Listed entityAster Dm Quality Care Limited
- Exchange sectorHealthcare
Financials of Aster Prime Hospitals
Exchange-reported figures of Aster Dm Quality Care Limited, the listed company behind Aster Prime Hospitals (NSE: ASTERDM).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 4,643 | 4,138 | 3,699 | 2,994 | 10,253 | 8,608 | 8,652 |
| Revenue growth | +12.2% | +11.9% | +23.5% | -70.8% | +19.1% | -0.5% | - |
| EBITDA | 802 | 627 | 575 | 447 | 1,533 | 1,103 | 1,269 |
| EBITDA margin | +17.3% | +15.2% | +15.6% | +14.9% | +15.0% | +12.8% | +14.7% |
| Profit before tax | 570 | 5,542 | 268 | 511 | 637 | 205 | 330 |
| Net profit | 411 | 149 | 129 | 425 | 525 | 147 | 457 |
| Net profit margin | +8.9% | +3.6% | +3.5% | +14.2% | +5.1% | +1.7% | +5.3% |
| EPS (₹) | 7.49 | 107.66 | 2.59 | 8.51 | 10.53 | 2.97 | 5.57 |
| Balance sheet | |||||||
| Total assets | 7,172 | 5,770 | 6,703 | 11,221 | 9,787 | 9,069 | 9,824 |
| Net worth | 4,576 | 3,428 | 4,560 | 4,448 | 3,953 | 3,372 | 3,272 |
| Total debt | 2,220 | 2,018 | 1,384 | 5,700 | 4,907 | 4,804 | 5,605 |
| Cash & bank | 1,325 | 1,380 | 113 | 429 | 380 | 281 | 177 |
| Net working capital | 1,140 | 1,209 | 3,121 | 1,489 | 1,499 | 1,183 | 1,625 |
| Cash flow | |||||||
| Cash from operations | 656 | 425 | 158 | 1,834 | 1,314 | 1,569 | 1,223 |
| Cash from investing | (288) | 6,015 | (878) | (951) | (563) | (333) | (658) |
| Cash from financing | (304) | (6,358) | 1,053 | (817) | (686) | (1,116) | (675) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,311 | 1,182 | 1,186 | 1,197 | 1,078 | 1,000 | 1,050 | 1,086 |
| Revenue growth (YoY) | +21.6% | +18.2% | +13.0% | +10.2% | +7.6% | - | - | - |
| Other income | 37.03 | 36.53 | 27.97 | 28.25 | 33.18 | 31.28 | 32.99 | 35.24 |
| EBITDA | 142 | 224 | 174 | 235 | 197 | 156 | 162 | 217 |
| EBITDA margin | +10.8% | +18.9% | +14.7% | +19.7% | +18.3% | +15.6% | +15.4% | +20.0% |
| Depreciation | 69.29 | 67.24 | 67.67 | 66.12 | 63.22 | 63.95 | 62.21 | 62.27 |
| Interest | 31.21 | 29.99 | 31.46 | 30.76 | 30.77 | 32.43 | 30.77 | 31.46 |
| Profit before tax | 78.08 | 163 | 103 | 167 | 136 | 90.54 | 102 | 159 |
| Tax | 48.80 | 9.77 | 44.40 | 45.54 | 42.88 | 5.00 | 37.49 | 52.89 |
| Net profit | 29.28 | 154 | 58.65 | 121 | 93.56 | 85.54 | 64.39 | 106 |
| EPS (₹) | 0.31 | 2.71 | 1.02 | 2.13 | 1.67 | 1.58 | 1.14 | 1.94 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,616 | 2,320 | 2,036 | 1,534 | 1,116 | 747 | 760 |
| Revenue growth | +12.7% | +13.9% | +32.8% | +37.4% | +49.6% | -1.8% | - |
| EBITDA | 440 | 413 | 365 | 293 | 153 | 41.83 | 72.62 |
| EBITDA margin | +16.8% | +17.8% | +17.9% | +19.1% | +13.7% | +5.6% | +9.6% |
| Profit before tax | 374 | 6,288 | 209 | 182 | 89.96 | (68.04) | 64.61 |
| Net profit | 329 | 5,874 | 157 | 174 | 90.30 | (68.42) | 61.94 |
| Net profit margin | +12.6% | +253.1% | +7.7% | +11.3% | +8.1% | -9.2% | +8.2% |
| EPS (₹) | 5.17 | 124.30 | 3.14 | 3.47 | 1.81 | (1.38) | 1.22 |
| Balance sheet | |||||||
| Total assets | 5,771 | 4,590 | 4,179 | 3,853 | 3,502 | 3,309 | 3,308 |
| Net worth | 4,366 | 3,339 | 3,294 | 3,131 | 2,955 | 2,864 | 2,931 |
| Total debt | 1,347 | 1,200 | 841 | 697 | 521 | 417 | 349 |
| Cash & bank | 1,126 | 1,289 | 34.85 | 31.29 | 25.02 | 17.59 | 33.39 |
| Net working capital | 972 | 1,286 | (0.18) | 65.92 | (43.43) | (64.91) | (55.42) |
| Cash flow | |||||||
| Cash from operations | 387 | 367 | 413 | 246 | 78.34 | 41.66 | 98.00 |
| Cash from investing | (144) | 6,023 | (342) | (332) | (49.17) | (38.07) | 39.76 |
| Cash from financing | (244) | (6,298) | (67.09) | 92.20 | (17.69) | (12.35) | (126) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 726 | 655 | 666 | 682 | 613 | 574 | 576 | 605 |
| Revenue growth (YoY) | +18.4% | +14.2% | +15.5% | +12.8% | +8.4% | - | - | - |
| Other income | 39.03 | 40.55 | 31.41 | 44.64 | 38.43 | 35.13 | 37.29 | 46.74 |
| Total expenses | 689 | 594 | 544 | 532 | 484 | 485 | 488 | 476 |
| EBITDA | 37.20 | 60.64 | 121 | 149 | 129 | 88.48 | 88.14 | 129 |
| EBITDA margin | +5.1% | +9.3% | +18.2% | +21.9% | +21.1% | +15.4% | +15.3% | +21.3% |
| Depreciation | 41.32 | 37.57 | 39.45 | 39.12 | 37.88 | 37.76 | 35.55 | 36.57 |
| Interest | 24.02 | 20.98 | 22.11 | 22.54 | 21.64 | 23.25 | 21.55 | 19.34 |
| Profit before tax | 10.89 | 42.64 | 91.10 | 132 | 108 | 62.60 | 68.33 | 120 |
| Tax | 25.19 | 15.18 | 35.94 | 27.82 | 27.44 | 1.53 | 18.51 | 29.99 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,311 | 1,182 | 1,186 | 1,197 | 1,078 | 1,000 | 1,050 | 1,086 |
| Revenue growth (YoY) | +21.6% | +18.2% | +13.0% | +10.2% | +7.6% | - | - | - |
| Other income | 37.03 | 36.53 | 27.97 | 28.25 | 33.18 | 31.28 | 32.99 | 35.24 |
| EBITDA | 142 | 224 | 174 | 235 | 197 | 156 | 162 | 217 |
| EBITDA margin | +10.8% | +18.9% | +14.7% | +19.7% | +18.3% | +15.6% | +15.4% | +20.0% |
| Depreciation | 69.29 | 67.24 | 67.67 | 66.12 | 63.22 | 63.95 | 62.21 | 62.27 |
| Interest | 31.21 | 29.99 | 31.46 | 30.76 | 30.77 | 32.43 | 30.77 | 31.46 |
| Profit before tax | 78.08 | 163 | 103 | 167 | 136 | 90.54 | 102 | 159 |
| Tax | 48.80 | 9.77 | 44.40 | 45.54 | 42.88 | 5.00 | 37.49 | 52.89 |
| Net profit | 29.28 | 154 | 58.65 | 121 | 93.56 | 85.54 | 64.39 | 106 |
| EPS (₹) | 0.31 | 2.71 | 1.02 | 2.13 | 1.67 | 1.58 | 1.14 | 1.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 4,643 | 4,138 | 3,699 | 2,994 | 10,253 | 8,608 | 8,652 |
| Revenue growth | +12.2% | +11.9% | +23.5% | -70.8% | +19.1% | -0.5% | - |
| Other income | 164 | 5,296 | 31.73 | 353 | 51.20 | 53.49 | 37.87 |
| Total expenses | 3,842 | 3,511 | 3,124 | 2,547 | 8,720 | 7,506 | 7,383 |
| Employee cost | 848 | 760 | 676 | 542 | 3,264 | 2,755 | 2,904 |
| EBITDA | 802 | 627 | 575 | 447 | 1,533 | 1,103 | 1,269 |
| EBITDA margin | +17.3% | +15.2% | +15.6% | +14.9% | +15.0% | +12.8% | +14.7% |
| Depreciation | 264 | 249 | 220 | 192 | 641 | 618 | 586 |
| Interest | 132 | 133 | 119 | 95.97 | 307 | 334 | 391 |
| Profit before tax | 570 | 5,542 | 268 | 511 | 637 | 205 | 330 |
| Tax | 143 | 134 | 56.51 | 35.87 | 35.80 | 27.22 | 15.38 |
| Net profit | 411 | 149 | 129 | 425 | 525 | 147 | 457 |
| Net profit margin | +8.9% | +3.6% | +3.5% | +14.2% | +5.1% | +1.7% | +5.3% |
| EPS (₹) | 7.49 | 107.66 | 2.59 | 8.51 | 10.53 | 2.97 | 5.57 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 893 | 874 | 874 | 874 | 874 | 497 | 497 |
| Reserves & surplus | 3,683 | 2,554 | 3,686 | 3,574 | 3,080 | 2,501 | 2,401 |
| Shareholders' funds (net worth) | 4,576 | 3,428 | 4,560 | 4,448 | 3,953 | 3,372 | 3,272 |
| Minority interest | 258 | 223 | 470 | 412 | 529 | 462 | 446 |
| Secured loans | 657 | 642 | 653 | 2,274 | 2,192 | 1,913 | 2,916 |
| Unsecured loans | 1,563 | 1,376 | 730 | 3,426 | 2,715 | 2,891 | 2,689 |
| Total debt | 2,220 | 2,018 | 1,384 | 5,700 | 4,907 | 4,804 | 5,605 |
| Total liabilities | 7,172 | 5,770 | 6,703 | 11,221 | 9,787 | 9,069 | 9,824 |
| Assets | |||||||
| Gross block | 5,632 | 5,136 | 4,529 | 12,663 | 9,771 | 9,116 | 9,187 |
| Net block | 4,242 | 3,920 | 3,175 | 9,052 | 7,009 | 6,749 | 7,124 |
| Capital work in progress | 420 | 293 | 170 | 279 | 998 | 934 | 736 |
| Investments | 1,167 | 245 | 17.04 | 79.55 | 44.83 | 62.86 | 34.35 |
| Inventories | 91.16 | 92.35 | 111 | 1,306 | 1,026 | 849 | 961 |
| Sundry debtors | 307 | 258 | 233 | 2,336 | 2,021 | 2,019 | 2,366 |
| Cash & bank balances | 1,325 | 1,380 | 113 | 429 | 380 | 281 | 177 |
| Loans & advances | 223 | 170 | 13,705 | 840 | 664 | 456 | 580 |
| Total current assets | 1,946 | 1,900 | 14,162 | 4,910 | 4,090 | 3,605 | 4,084 |
| Total current liabilities | 807 | 691 | 11,041 | 3,422 | 2,591 | 2,422 | 2,459 |
| Net working capital | 1,140 | 1,209 | 3,121 | 1,489 | 1,499 | 1,183 | 1,625 |
| Total assets | 7,172 | 5,770 | 6,703 | 11,221 | 9,787 | 9,069 | 9,824 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 165 | 82.23 | 365 | 299 | 235 | 115 | 225 |
| Net cash from operating activities | 656 | 425 | 158 | 1,834 | 1,314 | 1,569 | 1,223 |
| Net cash from investing activities | (288) | 6,015 | (878) | (951) | (563) | (333) | (658) |
| Net cash from financing activities | (304) | (6,358) | 1,053 | (817) | (686) | (1,116) | (675) |
| Net change in cash | 63.48 | 82.36 | 332 | 65.74 | 64.78 | 120 | (110) |
| Closing cash | 1,325 | 1,380 | 113 | 429 | 380 | 281 | 177 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +12.2% | +11.9% | +23.5% | -70.8% | +19.1% | -0.5% | - |
| EBITDA growth | +27.8% | +9.0% | +28.8% | -70.9% | +39.0% | -13.1% | - |
| PBT growth | -89.7% | +1967.5% | -47.6% | -19.7% | +210.6% | -37.9% | -19.6% |
| Net income growth | +176.0% | +15.5% | -69.6% | -19.1% | +256.1% | -67.7% | - |
| Revenue CAGR (3Y) | +15.8% | -26.1% | -24.5% | -29.8% | +8.8% | +8.6% | +13.4% |
| EBITDA CAGR (3Y) | +21.5% | -25.8% | -19.5% | -29.4% | +20.0% | +20.4% | +95.8% |
| Profitability & leverage | |||||||
| Net income margin | +9.2% | +130.7% | +5.7% | +15.9% | +5.9% | +2.1% | +3.6% |
| Return on capital employed | +11.8% | +11.6% | +4.8% | +3.0% | +10.5% | +5.9% | +11.2% |
| Return on net worth | +12.7% | +5.4% | +5.7% | +13.1% | +17.1% | +5.1% | +14.2% |
| Debt / equity | 0.58 | 0.47 | 0.87 | 1.33 | 1.33 | 1.57 | 1.29 |
| Long-term debt / equity | 0.53 | 0.41 | 0.69 | 1.05 | 1.09 | 1.26 | 0.97 |
| Interest cover | 24.50 | 35.04 | 33.50 | 37.70 | 34.38 | 68.76 | 57.22 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.92 | 0.93 | 0.45 | 0.27 | 1.09 | 0.94 | 1.15 |
| Inventory turnover | 50.60 | 40.80 | 5.22 | 2.57 | 10.94 | 9.51 | 10.22 |
| Debtors turnover | 16.44 | 16.85 | 2.88 | 1.37 | 5.08 | 3.93 | 3.94 |
| EPS (₹) | 7.49 | 107.66 | 2.59 | 8.51 | 10.53 | 2.97 | 5.57 |
| Dividend per share (₹) | 3.00 | 5.00 | 120.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 74.36 | 54.15 | 75.42 | 73.19 | 71.65 | 60.32 | 58.33 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 726 | 655 | 666 | 682 | 613 | 574 | 576 | 605 |
| Revenue growth (YoY) | +18.4% | +14.2% | +15.5% | +12.8% | +8.4% | - | - | - |
| Other income | 39.03 | 40.55 | 31.41 | 44.64 | 38.43 | 35.13 | 37.29 | 46.74 |
| Total expenses | 689 | 594 | 544 | 532 | 484 | 485 | 488 | 476 |
| EBITDA | 37.20 | 60.64 | 121 | 149 | 129 | 88.48 | 88.14 | 129 |
| EBITDA margin | +5.1% | +9.3% | +18.2% | +21.9% | +21.1% | +15.4% | +15.3% | +21.3% |
| Depreciation | 41.32 | 37.57 | 39.45 | 39.12 | 37.88 | 37.76 | 35.55 | 36.57 |
| Interest | 24.02 | 20.98 | 22.11 | 22.54 | 21.64 | 23.25 | 21.55 | 19.34 |
| Profit before tax | 10.89 | 42.64 | 91.10 | 132 | 108 | 62.60 | 68.33 | 120 |
| Tax | 25.19 | 15.18 | 35.94 | 27.82 | 27.44 | 1.53 | 18.51 | 29.99 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,616 | 2,320 | 2,036 | 1,534 | 1,116 | 747 | 760 |
| Revenue growth | +12.7% | +13.9% | +32.8% | +37.4% | +49.6% | -1.8% | - |
| Other income | 180 | 6,111 | 49.02 | 49.77 | 82.20 | 21.63 | 115 |
| Total expenses | 2,175 | 1,908 | 1,671 | 1,241 | 963 | 705 | 688 |
| Employee cost | 403 | 375 | 318 | 231 | 172 | 144 | 130 |
| EBITDA | 440 | 413 | 365 | 293 | 153 | 41.83 | 72.62 |
| EBITDA margin | +16.8% | +17.8% | +17.9% | +19.1% | +13.7% | +5.6% | +9.6% |
| Depreciation | 154 | 145 | 121 | 104 | 98.72 | 95.00 | 89.32 |
| Interest | 92.63 | 91.18 | 83.43 | 56.50 | 46.82 | 36.50 | 33.20 |
| Profit before tax | 374 | 6,288 | 209 | 182 | 89.96 | (68.04) | 64.61 |
| Tax | 106 | 79.28 | 52.39 | 9.04 | (0.22) | 0.74 | 4.00 |
| Net profit | 329 | 5,874 | 157 | 174 | 90.30 | (68.42) | 61.94 |
| Net profit margin | +12.6% | +253.1% | +7.7% | +11.3% | +8.1% | -9.2% | +8.2% |
| EPS (₹) | 5.17 | 124.30 | 3.14 | 3.47 | 1.81 | (1.38) | 1.22 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 893 | 874 | 874 | 874 | 874 | 497 | 497 |
| Reserves & surplus | 3,474 | 2,466 | 2,420 | 2,257 | 2,081 | 1,993 | 2,059 |
| Shareholders' funds (net worth) | 4,366 | 3,339 | 3,294 | 3,131 | 2,955 | 2,864 | 2,931 |
| Secured loans | 304 | 377 | 371 | 289 | 198 | 152 | 88.88 |
| Unsecured loans | 1,043 | 823 | 471 | 408 | 323 | 265 | 260 |
| Total debt | 1,347 | 1,200 | 841 | 697 | 521 | 417 | 349 |
| Total liabilities | - | - | 4,179 | 3,853 | 3,502 | 3,309 | 3,308 |
| Assets | |||||||
| Gross block | 3,028 | 2,667 | 2,088 | 1,646 | 1,552 | 1,450 | 1,363 |
| Net block | 1,972 | 1,760 | 1,333 | 1,008 | 1,013 | 1,009 | 1,016 |
| Capital work in progress | 160 | 55.41 | 38.85 | 66.55 | 22.91 | 10.90 | 20.15 |
| Investments | 2,216 | 1,009 | 2,176 | 2,141 | 2,166 | 2,151 | 2,150 |
| Inventories | 33.24 | 41.73 | 43.55 | 34.28 | 23.63 | 19.53 | 23.75 |
| Sundry debtors | 179 | 138 | 128 | 111 | 61.55 | 42.92 | 44.78 |
| Cash & bank balances | 1,126 | 1,289 | 34.85 | 31.29 | 25.02 | 17.59 | 33.39 |
| Loans & advances | 173 | 143 | 108 | 138 | 89.58 | 118 | 71.17 |
| Total current assets | 1,511 | 1,612 | 314 | 315 | 200 | 198 | 173 |
| Total current liabilities | 538 | 325 | 314 | 249 | 243 | 263 | 229 |
| Net working capital | 972 | 1,286 | (0.18) | 65.92 | (43.43) | (64.91) | (55.42) |
| Total assets | 5,771 | 4,590 | 4,179 | 3,853 | 3,502 | 3,309 | 3,308 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 120 | 27.72 | 24.38 | 18.27 | 6.79 | 15.55 | 3.49 |
| Net cash from operating activities | 387 | 367 | 413 | 246 | 78.34 | 41.66 | 98.00 |
| Net cash from investing activities | (144) | 6,023 | (342) | (332) | (49.17) | (38.07) | 39.76 |
| Net cash from financing activities | (244) | (6,298) | (67.09) | 92.20 | (17.69) | (12.35) | (126) |
| Net change in cash | (0.40) | 92.12 | 3.34 | 6.11 | 11.48 | (8.76) | 12.06 |
| Closing cash | 1,126 | 1,289 | 34.85 | 31.29 | 25.02 | 17.59 | 33.39 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +12.7% | +13.9% | +32.8% | +37.4% | +49.6% | -1.8% | - |
| EBITDA growth | +6.8% | +13.0% | +24.6% | +91.2% | +266.5% | -42.4% | - |
| PBT growth | -94.1% | +2903.7% | +14.8% | +102.7% | +9998.0% | - | +33.2% |
| Net income growth | -94.4% | +3631.9% | -9.3% | +92.2% | +232.0% | -210.5% | - |
| Revenue CAGR (3Y) | +19.5% | +27.6% | +39.7% | +26.4% | +23.4% | +12.1% | +26.1% |
| EBITDA CAGR (3Y) | +14.5% | +39.1% | +105.9% | +59.2% | +57.0% | +62.6% | - |
| Profitability & leverage | |||||||
| Net income margin | +10.2% | +267.6% | +7.7% | +11.3% | +8.1% | -9.2% | +8.0% |
| Return on capital employed | +10.9% | +147.3% | +7.4% | +6.4% | +3.9% | 0.0% | +2.8% |
| Return on net worth | +9.6% | +214.9% | +5.6% | +6.4% | +3.2% | 0.0% | +1.9% |
| Debt / equity | 0.34 | 0.31 | 0.24 | 0.20 | 0.16 | 0.13 | 0.08 |
| Long-term debt / equity | 0.31 | 0.28 | 0.20 | 0.16 | 0.13 | 0.10 | 0.04 |
| Interest cover | 32.34 | 34.01 | 34.23 | 29.88 | 85.78 | -68.65 | -198.80 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.94 | 1.00 | 1.12 | 0.98 | 0.74 | 0.53 | 0.64 |
| Inventory turnover | 69.78 | 54.42 | 52.33 | 52.97 | 51.74 | 34.50 | 38.81 |
| Debtors turnover | 16.50 | 17.47 | 17.05 | 17.74 | 21.37 | 17.02 | 19.01 |
| EPS (₹) | 5.17 | 124.30 | 3.14 | 3.47 | 1.81 | (1.38) | 1.22 |
| Dividend per share (₹) | 3.00 | 5.00 | 120.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 76.00 | 58.28 | 57.38 | 54.10 | 51.67 | 50.09 | 51.45 |
Similar companies to Aster Prime Hospitals
Aster Prime Hospitals has 3 listed similar companies in our database, 2 of them funded. They include Fortis Healthcare, Ujala Cygnus and Narayana Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fortishealthcare.com | 1996 | Gurugram, India | 1,565 | Multi-specialty hospital services are provided across India by Fortis Healthcare. | ||
| ujalacygnus.com | 2011 | Delhi, India | $36.74M | 2,084 | A chain of multi-specialty hospitals is operated in India. | |
| narayanahealth.org | 2000 | Bengaluru, India | $148.2M | 8,145 | A chain of multi-specialty hospitals is operated in India. |
Detailed similar companies of Aster Prime Hospitals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Aster Prime Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 4,459 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 321 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aster Prime Hospitals
Complete news archive for Aster Prime Hospitals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aster Prime Hospitals
Aster Prime Hospitals was founded in 2006.
Aster Prime Hospitals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Aster Prime Hospitals has 4,431 employees.
The primary company behind Aster Prime Hospitals, Aster Dm Quality Care Limited, reported revenue of ₹4,807 Cr for FY 2026, up 12% year on year.
Aster Prime Hospital is a private multi-speciality facility in Hyderabad, Telangana, offering quaternary medical care with state-of-the-art technology. It provides services in areas like cardiac sciences, neurology, and orthopaedics through skilled experts. The hospital focuses on diagnosis, treatment, and personalized care for faster patient recovery, serving local and international patients with round-the-clock support.
Aster Prime Hospitals's top competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health.
Aster Prime Hospitals offers Medical Consultation, Emergency Services, and Virtual Consultations.
Yes, Aster Prime Hospitals is publicly traded on NSE under the ticker symbol ASTERDM.
Aster Prime Hospitals operates through Aster Dm Quality Care Limited.
The legal entities of Aster Prime Hospitals currently have 14 directors, including Mandayapurath Azad Moopen, Alisha Moopen, Hemish Purushottam and others.